Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Levamisol hydrochloride compound preparations for eperythrozoonsis for animals and preparation thereof

A technology of eperythrozoonosis and levamisole hydrochloride, which is applied in the field of preparations and its preparation, and can solve the problems of inability to completely eliminate eperythrozoonosis and inability to purify eperythrozoonosis

Inactive Publication Date: 2008-07-09
SHANGHAI JIAO TONG UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Found through literature retrieval to prior art, relevant report is very few, and Huang Shuihong etc. published " the medicine curative effect exploration of porcine eperythrozoon disease " on the 2nd period of " contemporary animal husbandry " in 2004, proposed to use to Eperythrozoon Sensitive drugs "Xuechongjing", sulfa-methoxine sodium, oxytetracycline, chlortetracycline, metronidazole and doxycycline in the treatment of Eperythrozoon disease can reduce the infection intensity of Eperythrozoon to a certain extent, However, none of them can purify the Eperythrozoon in the blood, and the existence of Eperythrozoon can still be detected after the treatment of the disease, and neither can completely remove the Eperythrozoon disease in the blood.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The veterinary compound preparation containing levamisole hydrochloride is prepared by the following method:

[0028] (1) Weigh 3 g of levamisole hydrochloride, 5 g of imidazolide dipropionate, 2 g of artemether, 0.5 g of magnesium dichloride, 1 g of 1,2-propanediol, 4.5 g of refined soybean oil, 1 g of lecithin, and 2.5 g of glycerin by weight. ;

[0029] (2) Mix the above glycerin, refined soybean oil, and artemether;

[0030] (3) Add 1,2-propanediol to obtain a clear and transparent solution;

[0031] (4) Add lecithin and get a clear solution in a constant temperature water bath at 80°C;

[0032] (5) Dissolve levamisole hydrochloride, imidazolide dipropionate and magnesium chloride in water for injection;

[0033] (6) Mix and mix the solutions obtained in (4) and (5) to prepare a compound preparation containing levamisole hydrochloride.

[0034] The compound preparation containing levamisole hydrochloride prepared above is used to treat rats artificially infected with ep...

Embodiment 2

[0041] The veterinary compound containing levamisole hydrochloride is prepared by the following method:

[0042] (1) Weigh 12 g of levamisole hydrochloride, 15 g of imidazolide dipropionate, 10 g of artemether, 5 g of magnesium dichloride, 10 g of 1,2-propanediol, 13.5 g of refined soybean oil, 1.5 g of lecithin, and 6.5 g of glycerin by weight. ;

[0043] (2) Mix the above glycerin, refined soybean oil, and artemether;

[0044] (3) Add 1,2-propanediol to obtain a clear and transparent solution;

[0045] (4) Add lecithin and get a clear solution in a constant temperature water bath at 80°C;

[0046] (5) Dissolve levamisole hydrochloride, imidazolide dipropionate and magnesium chloride in water for injection;

[0047] (6) Mix the obtained solution and mix well to prepare a compound preparation containing levamisole hydrochloride.

[0048] The compound preparation containing levamisole hydrochloride prepared by the above method is used for in vitro anti-eperythrocyte susceptibility ...

Embodiment 3

[0067] The veterinary compound containing levamisole hydrochloride is prepared by the following method:

[0068] (1) Weigh 8 g of levamisole hydrochloride, 10 g of imidazolide dipropionate, 6 g of artemether, 3 g of magnesium dichloride, 10 ml of 1,2-propanediol, 9 g of refined soybean oil, 1.25 g of lecithin, and 4.5 g of glycerol by weight;

[0069] (2) Mix the prescription amount of glycerin, refined soybean oil, and artemether;

[0070] (3) Add 1,2-propanediol to obtain a clear and transparent solution;

[0071] (4) Add the prescribed amount of lecithin, and obtain a clear solution in a constant temperature water bath at 80°C;

[0072] (5) Dissolve levamisole hydrochloride, imidazolide dipropionate and magnesium chloride in water for injection;

[0073] (6) Mix and mix the solutions obtained in (4) and (5) to prepare a compound preparation containing levamisole hydrochloride.

[0074] The compound preparation containing levamisole hydrochloride prepared above is used for the t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a veterinary levamisole hydrochloride compound preparation used for the eperythrozoonosis in the biotechnical field and a preparation method thereof. The present invention considers the levamisole hydrochloride, imidocarb dipropionate and artemether as main materials to be matched with magnesium dichloride, 1, 2-propanediol, refined soybean oil, lecithin and glycerin to be processed by the methods of weighing, crushing, stirring, mixing, checking, measuring, packing, etc. Components and weight percentages are: 3 percent to 12 percent of the levamisole hydrochloride, 5 percent to 15 percent of the imidocarb dipropionate, 2 percent to 10 percent of the artemether, 0.5 percent to 5 percent of the magnesium dichloride, 1 percent to 10 percent of the 1, 2-propanediol, 5 percent to 15 percent of the refined soybean oil, 0.5 percent to 1 percent of the lecithin and 2 percent to 5 percent of the glycerin. The compound preparation of the present invention can be medicated by intramuscular injection and subcutaneous injection, which has the characteristics of low cost, stable storage, assured effect and eliminating eperythrozoon thoroughly.

Description

Technical field [0001] The invention relates to a preparation in the field of biological technology and a preparation method thereof, in particular to a veterinary compound preparation of levamisole hydrochloride for eperythrozoon disease and a preparation method thereof. Background technique [0002] Eperythrozoon is a zoonotic disease caused by the parasitism of eperythrozoon on the surface of red blood cells, plasma and bone marrow of humans and animals. Porcine eperythrocytosis mainly causes fever, anemia, jaundice and sow abortion in piglets. The disease is often mixed with other swine diseases. It is difficult to prevent and harm, and it causes huge economic losses to the pig industry. However, because eperythrozoonosis has just attracted the attention of producers in recent years, the theoretical accumulation and clinical experience of its prevention and treatment have just begun. At present, there is no safe, efficient and environmentally friendly specific therapeutic dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/429A61K31/357A61K31/4178A61P31/02
Inventor 华修国李政萍崔立杨志彪沈权
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products